↓ Skip to main content

How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review

Overview of attention for article published in BMC Cancer, September 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
49 Mendeley